Home Page
Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Donate Now
Access Resources

MJFF Publications
4931 - 4940 of 9156 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Racial Disparities Remain in Access to Deep Brain Stimulation
    2022
    Summary Details
    RESTRICTED
    Title: Racial Disparities Remain in Access to Deep Brain Stimulation
    Author(s): Susan Fitzgerald
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 22
    Issue #: 12
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000840588.90259.50
    Citation Count: 0
  • Planning for Prevention of Parkinson Disease
    2022
    Summary Details
    OPEN
    Title: Planning for Prevention of Parkinson Disease
    Author(s): Grace F. Crotty, Jessi L. Keavney, Roy N. Alcalay, Kenneth Marek, Gad A. Marshall, H. Diana Rosas, Michael A. Schwarzschild
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 7_Supplement_1
    Start Page: 1
    End Page: 9
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200789
    Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/1.full.pdf
    Citation Count: 30
  • What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?
    2022
    Summary Details
    OPEN
    Title: What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?
    Author(s): John Seibyl, Phillip H. Kuo
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 7_Supplement_1
    Start Page: 61
    End Page: 67
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200786
    Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/61.full.pdf
    Citation Count: 21
  • Can Legislation Save the Day for Challenges Related to Prior Authorization?
    2022
    Summary Details
    RESTRICTED
    Title: Can Legislation Save the Day for Challenges Related to Prior Authorization?
    Author(s): Lola Butcher
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 22
    Issue #: 1
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000817608.36002.47
    Citation Count: 2
  • Facial Analysis Software Helps Screen for Parkinson's Disease
    2022
    Summary Details
    RESTRICTED
    Title: Facial Analysis Software Helps Screen for Parkinson's Disease
    Author(s): Richard Robinson
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 22
    Issue #: 1
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000817640.88538.ff
    Citation Count: 0
  • Association of Early Weight Change With Cognitive Decline in Patients With Parkinson Disease
    2022
    Summary Details
    RESTRICTED
    Title: Association of Early Weight Change With Cognitive Decline in Patients With Parkinson Disease
    Author(s): Ryul Kim, Seo Hee Choi, Kyeongho Byun, Nyeonju Kang, Young Ju Suh, Jin‐Sun Jun, Beomseok Jeon
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 100
    Issue #: 2
    Start Page: e232
    End Page: e241
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000201404
    Citation Count: 12
  • An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 Therapies
    2022
    Summary Details
    OPEN
    Title: An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 Therapies
    Author(s): Tyler L. Borko, Sean Selva, Ryan D. Baxter, Berenice Cabrera-Martinez, Cody Rester, Stefan Sillau, Daniel M. Pastula, Maite Sabalza, Iswariya Venkataraman, Eagappanath Thiruppathi, Jeffrey L. Bennett, Enrique Alarcón Álvarez, Robert A. Gross, Anna Shah, Ryan Kammeyer, Timothy L. Vollmer, Ross M. Kedl, John R. Corboy, Elena W.Y. Hsieh, Amanda L. Piquet
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 23_Supplement_2
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903428.98962.0a
    Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S52.full.pdf
    Citation Count: 1
  • Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)
    2022
    Summary Details
    OPEN
    Title: Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)
    Author(s): Jeffrey C. Allen, Eduardo Nobile‐Orazio, Stojan Perić, Hans Katzberg, Stéphanie Cadour, Inge Van de Walle, Iris van Hoomissen, Bert Jacquemyn, Olivier Van de Steen, W. Ludo van der Pol
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 23_Supplement_2
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903320.23411.f9
    Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S40.full.pdf
    Citation Count: 4
  • Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy Controls
    2022
    Summary Details
    OPEN
    Title: Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy Controls
    Author(s): Tyler L. Borko, Britney Barrera, Christopher Mizenko, Aurélie Ledreux, Ryan Kammeyer, Alanna Ritchie, Sean Selva, Stefan Sillau, Eric Engebretson, Rebecca Seale, Brooke Valdez, Jeffrey L. Bennett, Timothy L. Vollmer, Kavita Nair, Amanda L. Piquet
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 23_Supplement_2
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903096.36040.1d
    Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S8.full.pdf
    Citation Count: 0
  • Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSI
    2022
    Summary Details
    RESTRICTED
    Title: Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSI
    Author(s): Jannik Prasuhn, Martin Göttlich, Britt Ebeling, Sofia Kourou, Friederike Gerkan, Christina Bodemann, Sinja S. Großer, Katharina Reuther, Henrike Hanßen, Norbert Brüggemann
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 24
    Start Page: e2683
    End Page: e2692
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000201288
    Citation Count: 16
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.